• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对嗜酸性粒细胞作为门诊患者中早期区分新冠肺炎与甲型流感生物标志物的首次洞察。

First insight into eosinophils as a biomarker for the early distinction of COVID-19 from influenza A in outpatients.

作者信息

Cao Chuangjie, Xie Haitao, Guo Ruohan, Dou Chengyun, Tang Jian

机构信息

Department of Pathology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China.

Department of Clinical Laboratory Medicine, Institution of Microbiology and Infectious Diseases, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China.

出版信息

Exp Ther Med. 2025 Jan 22;29(3):56. doi: 10.3892/etm.2025.12806. eCollection 2025 Mar.

DOI:10.3892/etm.2025.12806
PMID:39885908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11775767/
Abstract

Coronavirus disease 2019 (COVID-19) and influenza A outbreaks have spread rapidly in China. It is difficult to accurately differentiate these two different respiratory tract infections on the basis of their similar early-stage symptoms and lymphocytopenia. In the present study, the age, sex and white blood cell, neutrophil, lymphocyte, monocyte and eosinophil counts, as well as the neutrophil-to-lymphocyte ratio (NLR) of 201 outpatients with confirmed COVID-19 and 246 outpatients with influenza A were investigated and compared. A receiver operating characteristic curve was drawn to determine the thresholds in distinguishing COVID-19 from influenza A Our study found that the monocyte count and NLR were significantly elevated, while the eosinophil count/percentage was higher in outpatients with COVID-19 than in those with influenza A (0.06±0.07 vs. 0.04±0.09, P=0.002; 0.95±1.12 vs. 0.56±0.95, P<0.001, respectively). Logit(P)=-1.11 + 1.29 x eosinophil percentage -12.07 x eosinophil count +1.10 x monocyte count, deduced from the eosinophil count/percentage and monocyte count, had the largest area under the curve at 0.67, with high specificity (80.1%) and a sensitivity of 47.3%. The present study demonstrated that a higher eosinophil count/percentage may be a potential biomarker to significantly differentiate early COVID-19 from influenza A.

摘要

2019冠状病毒病(COVID-19)和甲型流感疫情在中国迅速蔓延。基于这两种不同呼吸道感染相似的早期症状和淋巴细胞减少症,很难准确区分它们。在本研究中,对201例确诊COVID-19门诊患者和246例甲型流感门诊患者的年龄、性别、白细胞、中性粒细胞、淋巴细胞、单核细胞和嗜酸性粒细胞计数,以及中性粒细胞与淋巴细胞比值(NLR)进行了调查和比较。绘制了受试者工作特征曲线以确定区分COVID-19和甲型流感的阈值。我们的研究发现,COVID-19门诊患者的单核细胞计数和NLR显著升高,而嗜酸性粒细胞计数/百分比高于甲型流感门诊患者(分别为0.06±0.07对0.04±0.09,P=0.002;0.95±1.12对0.56±0.95,P<0.001)。根据嗜酸性粒细胞计数/百分比和单核细胞计数推导的Logit(P)= -1.11 + 1.29×嗜酸性粒细胞百分比 - 12.07×嗜酸性粒细胞计数 + 1.10×单核细胞计数,曲线下面积最大,为0.67,具有高特异性(80.1%)和47.3%的敏感性。本研究表明,较高的嗜酸性粒细胞计数/百分比可能是将早期COVID-19与甲型流感显著区分开来的潜在生物标志物。

相似文献

1
First insight into eosinophils as a biomarker for the early distinction of COVID-19 from influenza A in outpatients.对嗜酸性粒细胞作为门诊患者中早期区分新冠肺炎与甲型流感生物标志物的首次洞察。
Exp Ther Med. 2025 Jan 22;29(3):56. doi: 10.3892/etm.2025.12806. eCollection 2025 Mar.
2
Full blood count parameters for the detection of asthma inflammatory phenotypes.用于检测哮喘炎症表型的全血细胞计数参数。
Clin Exp Allergy. 2014 Sep;44(9):1137-45. doi: 10.1111/cea.12345.
3
Differentiating COVID-19 and influenza in children: hemogram parameters as diagnostic tools.儿童 COVID-19 和流感的鉴别:血常规参数作为诊断工具。
Front Public Health. 2024 Jul 11;12:1377785. doi: 10.3389/fpubh.2024.1377785. eCollection 2024.
4
Are Lymphocytes and Eosinophils Associated with the COVID-19 Severity: A Large, Retrospective Study.淋巴细胞和嗜酸性粒细胞与新冠病毒疾病严重程度相关吗:一项大型回顾性研究
Thorac Res Pract. 2023 Jan;24(1):6-13. doi: 10.5152/ThoracResPract.2023.21233.
5
Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters.利用血液学参数组合鉴别新冠肺炎重症与中症病例的初步研究
Ann Transl Med. 2020 May;8(9):593. doi: 10.21037/atm-20-3391.
6
Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization.单核细胞绝对计数作为区分需要住院治疗的患者感染新冠病毒和甲型/乙型流感的初步工具。
Infez Med. 2020 Dec 1;28(4):534-538.
7
Diagnostic value of routine blood tests in differentiating between SARS-CoV-2, influenza A, and RSV infections in hospitalized children: a retrospective study.常规血液检测在鉴别住院儿童中 2019 新型冠状病毒、甲型流感病毒和呼吸道合胞病毒感染中的诊断价值:一项回顾性研究。
BMC Pediatr. 2024 May 13;24(1):328. doi: 10.1186/s12887-024-04822-y.
8
Differentiating Between 2019 Novel Coronavirus Pneumonia and Influenza Using a Nonspecific Laboratory Marker-Based Dynamic Nomogram.使用基于非特异性实验室标志物的动态列线图鉴别2019新型冠状病毒肺炎和流感
Open Forum Infect Dis. 2020 May 16;7(5):ofaa169. doi: 10.1093/ofid/ofaa169. eCollection 2020 May.
9
Distinguishing between COVID-19 and influenza during the early stages by measurement of peripheral blood parameters.通过测量外周血参数在早期区分 COVID-19 和流感。
J Med Virol. 2021 Feb;93(2):1029-1037. doi: 10.1002/jmv.26384. Epub 2020 Aug 13.
10
Clinical and hematological characteristics of children infected with the omicron variant of SARS-CoV-2: role of the combination of the neutrophil: lymphocyte ratio and eosinophil count in distinguishing severe COVID-19.感染新冠病毒奥密克戎变异株儿童的临床和血液学特征:中性粒细胞与淋巴细胞比值和嗜酸性粒细胞计数联合在区分重症新冠肺炎中的作用
Front Pediatr. 2024 Jun 24;12:1305639. doi: 10.3389/fped.2024.1305639. eCollection 2024.

引用本文的文献

1
Correlation of Neutrophil-Lymphocyte Ratio and Critical Illness in Adults on Vancomycin: A Cross-Sectional Study.成人使用万古霉素时中性粒细胞与淋巴细胞比值与危重病的相关性:一项横断面研究。
Int J Gen Med. 2025 Jul 31;18:4157-4167. doi: 10.2147/IJGM.S537039. eCollection 2025.

本文引用的文献

1
Real-world effectiveness of influenza vaccine against medical-attended influenza infection during 2023/24 season in Ili Kazakh Autonomous Prefecture, China: A test-negative, case-control study.2023/24 季节中国伊犁哈萨克自治州真实世界中流感疫苗对有医疗记录的流感感染的有效性:一项病例对照研究,采用病例对照研究设计,检测阴性。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2394255. doi: 10.1080/21645515.2024.2394255. Epub 2024 Aug 29.
2
Epidemiological and clinical characteristics of COVID-19 reinfection during the epidemic period in Yangzhou city, Jiangsu province.江苏省扬州市疫情期间 COVID-19 再感染的流行病学和临床特征。
Front Public Health. 2023 Sep 13;11:1256768. doi: 10.3389/fpubh.2023.1256768. eCollection 2023.
3
The Associated Factors of SARS-CoV-2 Reinfection by Omicron Variant - Guangdong Province, China, December 2022 to January 2023.2022年12月至2023年1月中国广东省奥密克戎变异株再次感染新冠病毒的相关因素
China CDC Wkly. 2023 May 5;5(18):391-396. doi: 10.46234/ccdcw2023.075.
4
Eosinophils in Health and Disease: A State-of-the-Art Review.健康与疾病中的嗜酸性粒细胞:最新综述
Mayo Clin Proc. 2021 Oct;96(10):2694-2707. doi: 10.1016/j.mayocp.2021.04.025. Epub 2021 Sep 15.
5
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.Covid-19 疫苗在门诊和住院治疗环境中的有效性。
N Engl J Med. 2021 Oct 7;385(15):1355-1371. doi: 10.1056/NEJMoa2110362. Epub 2021 Sep 8.
6
Digital Droplet PCR for SARS-CoV-2 Resolves Borderline Cases.数字液滴 PCR 可解决 SARS-CoV-2 的边界案例。
Am J Clin Pathol. 2021 May 18;155(6):815-822. doi: 10.1093/ajcp/aqab041.
7
Eosinophils and COVID-19: diagnosis, prognosis, and vaccination strategies.嗜酸性粒细胞与 COVID-19:诊断、预后和疫苗接种策略。
Semin Immunopathol. 2021 Jun;43(3):383-392. doi: 10.1007/s00281-021-00850-3. Epub 2021 Mar 16.
8
Comparison of COVID-19 and influenza characteristics.新冠病毒与流感特征比较。
J Zhejiang Univ Sci B. 2021 Feb 15;22(2):87-98. doi: 10.1631/jzus.B2000479.
9
COVID-19: Characteristics and Therapeutics.新型冠状病毒肺炎(COVID-19):特征与治疗。
Cells. 2021 Jan 21;10(2):206. doi: 10.3390/cells10020206.
10
Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19.白细胞向肺部及其他部位的迁移:COVID-19 从流感中得到的教训。
Nat Rev Immunol. 2021 Jan;21(1):49-64. doi: 10.1038/s41577-020-00470-2. Epub 2020 Nov 19.